104 related articles for article (PubMed ID: 11908943)
1. Absence of CD5 dramatically reduces progression of pulmonary inflammatory lesions in SHP-1 protein-tyrosine phosphatase-deficient 'viable motheaten' mice.
Joliat MJ; Lang PA; Lyons BL; Burzenski L; Lynes MA; Yi T; Sundberg JP; Shultz LD
J Autoimmun; 2002 Mar; 18(2):105-17. PubMed ID: 11908943
[TBL] [Abstract][Full Text] [Related]
2. T cell developmental defects in 'viable motheaten' mice deficient in SHP-1 protein-tyrosine phosphatase. Developmental defects are corrected in vitro in the presence of normal hematopoietic-origin stromal cells and in vivo by exogenous IL-7.
Christianson SW; Greiner DL; Deluca D; Leif J; Phillips NE; Hayes SM; Hayashi S; Joliat MJ; Lyons BL; Shultz LD
J Autoimmun; 2002 Mar; 18(2):119-30. PubMed ID: 11908944
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of SHP-1 protein-tyrosine phosphatase in "viable motheaten" mice results in retinal degeneration.
Lyons BL; Smith RS; Hurd RE; Hawes NL; Burzenski LM; Nusinowitz S; Hasham MG; Chang B; Shultz LD
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1201-9. PubMed ID: 16505059
[TBL] [Abstract][Full Text] [Related]
4. DNA-binding antibodies from viable motheaten mutant mice: implications for B cell tolerance.
Westhoff CM; Whittier A; Kathol S; McHugh J; Zajicek C; Shultz LD; Wylie DE
J Immunol; 1997 Sep; 159(6):3024-33. PubMed ID: 9300728
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic cell protein-tyrosine phosphatase-deficient motheaten mice exhibit T cell apoptosis defect.
Su X; Zhou T; Yang PA; Wang Z; Mountz JD
J Immunol; 1996 Jun; 156(11):4198-208. PubMed ID: 8666788
[TBL] [Abstract][Full Text] [Related]
6. src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation.
Kamata T; Yamashita M; Kimura M; Murata K; Inami M; Shimizu C; Sugaya K; Wang CR; Taniguchi M; Nakayama T
J Clin Invest; 2003 Jan; 111(1):109-19. PubMed ID: 12511594
[TBL] [Abstract][Full Text] [Related]
7. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice.
Tapley P; Shevde NK; Schweitzer PA; Gallina M; Christianson SW; Lin IL; Stein RB; Shultz LD; Rosen J; Lamb P
Exp Hematol; 1997 Feb; 25(2):122-31. PubMed ID: 9015212
[TBL] [Abstract][Full Text] [Related]
8. SHP-1 regulates STAT6 phosphorylation and IL-4-mediated function in a cell type-specific manner.
Huang Z; Coleman JM; Su Y; Mann M; Ryan J; Shultz LD; Huang H
Cytokine; 2005 Feb; 29(3):118-24. PubMed ID: 15613279
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the hematopoietic cell phosphatase (Hcph) gene is associated with resistance to gamma-irradiation-induced apoptosis in Src homology protein tyrosine phosphatase (SHP)-1-deficient "motheaten" mutant mice.
Hsu HC; Shultz LD; Su X; Shi J; Yang PA; Relyea MJ; Zhang HG; Mountz JD
J Immunol; 2001 Jan; 166(2):772-80. PubMed ID: 11145649
[TBL] [Abstract][Full Text] [Related]
10. Functional consequences of the SHP-1 defect in motheaten viable mice: role of NF-kappa B.
Khaled AR; Butfiloski EJ; Sobel ES; Schiffenbauer J
Cell Immunol; 1998 Apr; 185(1):49-58. PubMed ID: 9636682
[TBL] [Abstract][Full Text] [Related]
11. Motheaten (me/me) mice deficient in SHP-1 are less susceptible to focal cerebral ischemia.
Beamer CA; Brooks DM; Lurie DI
J Neurosci Res; 2006 May; 83(7):1220-30. PubMed ID: 16528752
[TBL] [Abstract][Full Text] [Related]
12. Aberrant regulation of bone trace elements in motheaten and osteopetrosis mutant mice.
Yamada G; Nakamura S; Haraguchi R; Sakai M; Suzuki K; Miyado K; Hasuwa H; Ogino Y; Minami T; Tohno Y; Blum M; Shultz LD
Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):315-9. PubMed ID: 9593582
[TBL] [Abstract][Full Text] [Related]
13. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene.
Tsui HW; Siminovitch KA; de Souza L; Tsui FW
Nat Genet; 1993 Jun; 4(2):124-9. PubMed ID: 8348149
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of Src homology 2-containing phosphatase 1 results in abnormalities in murine neutrophil function: studies in motheaten mice.
Kruger J; Butler JR; Cherapanov V; Dong Q; Ginzberg H; Govindarajan A; Grinstein S; Siminovitch KA; Downey GP
J Immunol; 2000 Nov; 165(10):5847-59. PubMed ID: 11067945
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of anemia in SHP-1 protein tyrosine phosphatase-deficient "viable motheaten" mice.
Lyons BL; Lynes MA; Burzenski L; Joliat MJ; Hadjout N; Shultz LD
Exp Hematol; 2003 Mar; 31(3):234-43. PubMed ID: 12644021
[TBL] [Abstract][Full Text] [Related]
16. Estrogen induces normal murine CD5+ B cells to produce autoantibodies.
Ansar Ahmed S; Dauphinée MJ; Montoya AI; Talal N
J Immunol; 1989 Apr; 142(8):2647-53. PubMed ID: 2467934
[TBL] [Abstract][Full Text] [Related]
17. Loss of SHP-1 phosphatase alters cytokine expression in the mouse hindbrain following cochlear ablation.
Zhao J; Lurie DI
Cytokine; 2004 Oct; 28(1):1-9. PubMed ID: 15341919
[TBL] [Abstract][Full Text] [Related]
18. Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development.
Dubé N; Bourdeau A; Heinonen KM; Cheng A; Loy AL; Tremblay ML
Cancer Res; 2005 Nov; 65(21):10088-95. PubMed ID: 16267035
[TBL] [Abstract][Full Text] [Related]
19. Increased negative selection impairs neonatal B cell repertoire but does not directly lead to generation of disease-associated IgM auto-antibodies.
Cassady-Cain RL; Kaushik AK
Int Immunol; 2006 May; 18(5):661-9. PubMed ID: 16569683
[TBL] [Abstract][Full Text] [Related]
20. Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. II. Description of a microenvironmental defect for the generation of terminal deoxynucleotidyltransferase-positive bone marrow cells in vitro.
Medlock ES; Goldschneider I; Greiner DL; Shultz L
J Immunol; 1987 Jun; 138(11):3590-7. PubMed ID: 3584969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
